1. Инструкция по применению лекарственного препарата для медицинского применения Эстрожель®
2. R. J. Baber, N. Panay & A. Fenton the IMS Writing Group (2016) 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy, Climacteric, 19:2, 109-150, DOI: 10.3109/13697137.2015.1129166
O’Sullivan et al. J. Clin. Invest. Volume 102, Number 5, September 1998, 1035–1040.
3. Российская Ассоциация Репродукции Человека, научно-практические рекомендации. Применение эстрогенов в программах ВРТ. 2015.
4. Клинические рекомендации МЗ РФ ≪Менопауза и климактерическое состояние у женщины≫, 2021.
5. Ramirez, E. De la Viuda et al., Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Espanola de Ginecologia y Obstetricia and Sociedad Espanola de Trombosis y Hemostasia Maturitas 2020 13757-62 DOI: (10.1016/j.maturitas.2020.04.019);
6. Cagnacci A, Bonaccorsi G, Gambacciani M; board of the Italian Menopause Society. Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued? Maturitas. 2020 Aug;138:76-77. doi: 10.1016/j.maturitas.2020.05.022. Epub 2020 Jun 18. PMID: 32565009; PMCID: PMC7301099;
7. A. Ribeiro Pires, Risk of venous thromboembolism in users of contraception and menopausal hormone therapy during the COVID-19 pandemic, Rev. Assoc. Med. Bras. vol.66 supl.2 Sao Paulo 2020 Epub Sep 21, 2020 http://dx.doi.org/10.1590/1806-9282.66.s2.22 SPECIAL ISSUE ARTICLE;
8. DOI of original article: https://doi.org/10.1016/j.maturitas.2020.06.014;
9. Seeland, U., Coluzzi, F., Simmaco, M. et al. Evidence for treatment with estradiol for women with SARS-CoV-2 infection. BMC Med 18, 369 (2020). https://doi.org/10.1186/s12916-020-01851-z
10.
https://www.fda.gov/media/71474/download